AJP - Heart  AJP: Regulatory, Integrative and Comparative Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 282: H437-H444, 2002. First published October 25, 2001; doi:10.1152/ajpheart.00723.2001
0363-6135/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/2/H437    most recent
00723.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (29)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morrison, R. R.
Right arrow Articles by Mustafa, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morrison, R. R.
Right arrow Articles by Mustafa, S. J.
Vol. 282, Issue 2, H437-H444, February 2002

Cardiac effects of adenosine in A2A receptor knockout hearts: uncovering A2B receptors

R. Ray Morrison1, M. A. Hassan Talukder2, Catherine Ledent3, and S. Jamal Mustafa2

Departments of 1 Pediatrics and 2 Pharmacology, The Brody School of Medicine at East Carolina University, Greenville, North Carolina 27858; and 3 Universite Libre de Bruxelles, 1070 Brussels, Belgium

To clarify the relative roles of A2 adenosine receptor subtypes in the regulation of coronary flow and myocardial contractility, coronary vascular and functional responses to adenosine and its analogs were examined in isolated wild-type (WT) and A2A receptor knockout (A2AKO) mouse hearts. Nonselective agonists adenosine and 5'-N-ethyl-carboxamido-adenosine (NECA) increased coronary flow in A2AKO hearts, albeit with a rightward shift of concentration-response curves and decreased maximal vasodilation compared with WT hearts. 2-p-(2-Carboxy-ethyl)phenethylamino-5'-N-ethyl-carboxamidoadenosine (CGS-21680, a selective A2A receptor agonist) increased coronary flow in WT hearts but did not affect A2AKO hearts. Adenosine and NECA each elicited equal maximal increases in developed pressure in WT and A2AKO hearts, whereas CGS-21680 did not affect developed pressure in A2AKO hearts. Alloxazine, a selective A2B receptor antagonist, attenuated NECA-induced coronary vasodilation (from 202 ± 14% to 128 ± 9% of baseline, P < 0.05) and NECA-induced increases in developed pressure (from 133 ± 8% to 112 ± 7% of baseline, P < 0.05) in A2AKO hearts. Together, these findings support the conclusion that A2B adenosine receptor activation increases coronary flow and developed pressure in isolated murine hearts.

Langendorff mouse hearts; adenosine analogs; coronary circulation; developed pressure


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. R. Morrison, X. L. Tan, C. Ledent, S. J. Mustafa, and P. A. Hofmann
Targeted deletion of A2A adenosine receptors attenuates the protective effects of myocardial postconditioning
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2523 - H2529.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Loffler, J. C. Morote-Garcia, S. A. Eltzschig, I. R. Coe, and H. K. Eltzschig
Physiological Roles of Vascular Nucleoside Transporters
Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1004 - 1013.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. R. Morrison, B. Teng, P. J. Oldenburg, L. C. Katwa, J. B. Schnermann, and S. J. Mustafa
Effects of targeted deletion of A1 adenosine receptors on postischemic cardiac function and expression of adenosine receptor subtypes
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1875 - H1882.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. Madonna, L. Rinaldi, C. Rossi, Y.-J. Geng, and R. De Caterina
Prostacyclin improves transcoronary myocardial delivery of adipose tissue-derived stromal cells
Eur. Heart J., September 1, 2006; 27(17): 2054 - 2061.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. E. Tawfik, B. Teng, R. R. Morrison, J. Schnermann, and S. J. Mustafa
Role of A1 adenosine receptor in the regulation of coronary flow
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H467 - H472.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Teng, H. R. Ansari, P. J. Oldenburg, J. Schnermann, and S. J. Mustafa
Isolation and characterization of coronary endothelial and smooth muscle cells from A1 adenosine receptor-knockout mice
Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1713 - H1720.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. I. Tikh, R. A. Fenton, and J. G. Dobson Jr.
Contractile effects of adenosine A1 and A2A receptors in isolated murine hearts
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H348 - H356.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. M. Marin and K. G. Franchini
Reduced oxygen supply explains the negative force-frequency relation and the positive inotropic effect of adenosine in buffer-perfused hearts
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H131 - H136.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Teng, W. Qin, H. R. Ansari, and S. J. Mustafa
Involvement of p38-mitogen-activated protein kinase in adenosine receptor-mediated relaxation of coronary artery
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2574 - H2580.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. E. Tawfik, J. Schnermann, P. J. Oldenburg, and S. J. Mustafa
Role of A1 adenosine receptors in regulation of vascular tone
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1411 - H1416.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Zhao, A. Linke, X. Xu, M. Ochoa, F. Belloni, L. Belardinelli, and T. H. Hintze
Comparative Profile of Vasodilation by CVT-3146, a Novel A2A Receptor Agonist, and Adenosine in Conscious Dogs
J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 182 - 189.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. A. H. Talukder, R. R. Morrison, M. A. Jacobson, K. A. Jacobson, C. Ledent, and S. J. Mustafa
Targeted deletion of adenosine A3 receptors augments adenosine-induced coronary flow in isolated mouse heart
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2183 - H2189.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. A. H. Talukder, R. R. Morrison, M. A. Jacobson, K. A. Jacobson, C. Ledent, and S. J. Mustafa
Targeted deletion of adenosine A3 receptors augments adenosine-induced coronary flow in isolated mouse heart
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2183 - H2189.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online